COMMUNIQUÉS West-GlobeNewswire

Allies for Every Child joins forces with RaiseAChild and UCLA TIES for Families creating The Community Collaborative, a network with a shared purpose of reimagining the experience of children and families within the foster care community
26/09/2019
LOS ANGELES, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Allies for Every Child, along with RaiseAChild and UCLA TIES for Families, are excited to announce they are the founding members of The Community Collaborative, a network [...]
T2 Biosystems to Present at the 2019 Cantor Global Healthcare Conference
26/09/2019
LEXINGTON, Mass., Sept. 26, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced today that John [...]
GENFIT Reinforces Corporate Leadership in the U.S.
26/09/2019
GENFIT Reinforces Corporate Leadership in the U.S. Lille (France), Cambridge (Massachusetts, United States), September 26, 2019 – GENFIT (Nasdaq and Euronext: GNFT) , a late-stage biopharmaceutical company dedicated to [...]
GENFIT renforce son équipe dirigeante aux États-Unis
26/09/2019
GENFIT renforce son équipe dirigeante aux États-Unis Lille (France), Cambridge (Massachusetts, États-Unis), le 26 septembre 2019 – GENFIT (Nasdaq et Euronext : GNFT) , société biopharmaceutique de phase avancée [...]
Kaleido Biosciences Announces CFO Transition
26/09/2019
LEXINGTON, Mass., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to leveraging the microbiome organ to treat disease and [...]
Plus Therapeutics, Inc. Announces Closing of $15 Million Underwritten Public Offering
26/09/2019
AUSTIN, Texas, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV ) (the “Company”) today announced the closing of its previously announced underwritten public offering (the “Offering”) of 3,000, [...]
Minerva Neurosciences to Host Conference Call and Live Webcast on Tuesday, October 1 at 8:30 AM ET
26/09/2019
WALTHAM, Mass., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) [...]
XOMA Acquires Royalty Interest Position in Six Clinical-Stage Assets
26/09/2019
Includes royalty interest in NIR178 EMERYVILLE, Calif., Sept. 26, 2019 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), announced today it has acquired a royalty interest in six clinical-stage assets targeting the [...]
Otonomy to Present at the Cantor Global Healthcare Conference
26/09/2019
SAN DIEGO, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that David A. Weber, Ph.D [...]
Menlo Therapeutics to Present at the 2019 Cantor Global Healthcare Conference
26/09/2019
REDWOOD CITY, Calif., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus (itch), [...]
Evelo Biosciences to Present at the 2019 Cantor Global Healthcare Conference
26/09/2019
CAMBRIDGE, Mass,, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing orally delivered, systemically acting biologics, today announced that [...]
MyoKardia to Present at 2019 Cantor Global Healthcare Conference
26/09/2019
SOUTH SAN FRANCISCO, Calif., Sept. 26, 2019 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), today announced that Taylor Harris, Chief Financial Officer, will participate in a fireside chat at the 2019 Cantor Global [...]
AGTC Announces Financial Results and Business Update for the Fourth Quarter and Fiscal Year Ended June 30, 2019
26/09/2019
Company announces promising topline six-month dose escalation data from its ongoing Phase 1/2 clinical trials for X-linked retinitis pigmentosa (XLRP) Preliminary three-month XLRP dose expansion data demonstrates [...]
Nabriva to Present Data from XENLETA (lefamulin) and CONTEPO (fosfomycin) Development Programs at IDWeek 2019
26/09/2019
DUBLIN, Ireland, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat [...]
Cara Therapeutics to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
26/09/2019
STAMFORD, Conn., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities with a primary focus on pruritus by [...]
Stemline Therapeutics to Present at the 2019 Cantor Global Healthcare Conference
26/09/2019
NEW YORK, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics, [...]
Cytokinetics Announces Additional Results From FORTITUDE-ALS to be Presented at the 18th Annual NEALS Meeting
26/09/2019
SOUTH SAN FRANCISCO, Calif., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that additional results from FORTITUDE-ALS ( F unctional O utcomes in a R andomized T rial of I [...]
Cytokinetics to Present at the Cantor Fitzgerald Global Healthcare Conference
26/09/2019
SOUTH SAN FRANCISCO, Calif., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK ) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to present a corporate [...]
European Commission Approves Trogarzo®
26/09/2019
MONTREAL, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that Trogarzo ® (ibalizumab) was approved today by the European Commission. “The approval of [...]

Pages